Forschung
Lehre
Lösungen
Anmelden
DE
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
PL - Polish
RU - Russian
Hansjörg Wyss Department of Plastic Surgery
Piul S. Rabbani has not added Biography.
If you are Piul S. Rabbani and would like to personalize this page please email our Author Liaison for assistance.
Novel lipoproteoplex delivers Keap1 siRNA based gene therapy to accelerate diabetic wound healing.
Biomaterials 07, 2017 | Pubmed ID: 28391065
The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus.
Journal of diabetes research , 2017 | Pubmed ID: 28913364
Targeted Nrf2 activation therapy with RTA 408 enhances regenerative capacity of diabetic wounds.
Diabetes research and clinical practice May, 2018 | Pubmed ID: 29476889
Dysregulation of Nrf2/Keap1 Redox Pathway in Diabetes Affects Multipotency of Stromal Cells.
Diabetes Oct, 2018 | Pubmed ID: 30352880
New York University School of Medicine
Piul S. Rabbani1,
Salma A. Abdou1,
Darren L. Sultan1,
Jennifer Kwong1,
April Duckworth1,
Daniel J. Ceradini1
1Hansjörg Wyss Department of Plastic Surgery, New York University School of Medicine
Datenschutz
Nutzungsbedingungen
Richtlinien
Kontakt
BIBLIOTHEKS-EMPFEHLUNG
JoVE-Newsletter
JoVE Journal
Methodensammlungen
JoVE Encyclopedia of Experiments
Archiv
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Ressourcen für Lehrende
Autoren
Bibliothekare
Zugang
ÜBER JoVE
Copyright © 2025 MyJoVE Corporation. Alle Rechte vorbehalten